Reproducibility of human cardiac phosphorus MRS (31P‐MRS) at 7 T
Purpose We test the reproducibility of human cardiac phosphorus MRS (31P‐MRS) at ultra‐high field strength (7 T) for the first time. The primary motivation of this work was to assess the reproducibility of a ‘rapid’ 6½ min 31P three‐dimensional chemical shift imaging (3D‐CSI) sequence, which if suff...
Saved in:
Published in | NMR in biomedicine Vol. 32; no. 6; pp. e4095 - n/a |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.06.2019
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
ISSN | 0952-3480 1099-1492 1099-1492 |
DOI | 10.1002/nbm.4095 |
Cover
Abstract | Purpose
We test the reproducibility of human cardiac phosphorus MRS (31P‐MRS) at ultra‐high field strength (7 T) for the first time. The primary motivation of this work was to assess the reproducibility of a ‘rapid’ 6½ min 31P three‐dimensional chemical shift imaging (3D‐CSI) sequence, which if sufficiently reproducible would allow the study of stress‐response processes. We compare this with an established 28 min protocol, designed to record high‐quality spectra in a clinically feasible scan time. Finally, we use this opportunity to compare the effect of per‐subject B0 shimming on data quality and reproducibility in the 6½ min protocol.
Methods
10 healthy subjects were scanned on two occasions: one to test the 28 min 3D‐CSI protocol, and one to test the 6½ min protocol. Spectra were fitted using the OXSA MATLAB toolbox. The phosphocreatine to adenosine triphosphate concentration ratio (PCr/ATP) from each scan was analysed for intra‐ and intersubject variability. The impact of different strategies for voxel selection was assessed.
Results
There were no significant differences between repeated measurements in the same subject. For the 28 min protocol, PCr/ATP in the midseptal voxel across all scans was 1.91 ± 0.36 (mean ± intersubject SD). For the 6½ min protocol, PCr/ATP in the midseptal voxel was 1.76 ± 0.40. The coefficients of reproducibility (CRs) were 0.49 (28 min) and 0.67 (6½ min). Per‐subject B0 shimming improved the fitted PCr/ATP precision (for 6½ min scans), but had negligible effect on the CR (0.67 versus 0.66).
Conclusions
Both 7 T protocols show improved reproducibility compared with a previous 3 T study by Tyler et al. Our results will enable informed power calculations and protocol selection for future clinical research studies.
We test the reproducibility of two 3D 31P‐MRS CSI protocols at 7 T: one lasting 28 minutes and one lasting 6½ minutes. We observed improved reproducibility even in 6 ½ minutes at 7 T compared to previously reported results for a 31 minute scan at 3 T. Our findings can be used for power calculations when designing future clinical studies using 7 T 31P‐MRS as an endpoint. |
---|---|
AbstractList | Purpose
We test the reproducibility of human cardiac phosphorus MRS (31P‐MRS) at ultra‐high field strength (7 T) for the first time. The primary motivation of this work was to assess the reproducibility of a ‘rapid’ 6½ min 31P three‐dimensional chemical shift imaging (3D‐CSI) sequence, which if sufficiently reproducible would allow the study of stress‐response processes. We compare this with an established 28 min protocol, designed to record high‐quality spectra in a clinically feasible scan time. Finally, we use this opportunity to compare the effect of per‐subject B0 shimming on data quality and reproducibility in the 6½ min protocol.
Methods
10 healthy subjects were scanned on two occasions: one to test the 28 min 3D‐CSI protocol, and one to test the 6½ min protocol. Spectra were fitted using the OXSA MATLAB toolbox. The phosphocreatine to adenosine triphosphate concentration ratio (PCr/ATP) from each scan was analysed for intra‐ and intersubject variability. The impact of different strategies for voxel selection was assessed.
Results
There were no significant differences between repeated measurements in the same subject. For the 28 min protocol, PCr/ATP in the midseptal voxel across all scans was 1.91 ± 0.36 (mean ± intersubject SD). For the 6½ min protocol, PCr/ATP in the midseptal voxel was 1.76 ± 0.40. The coefficients of reproducibility (CRs) were 0.49 (28 min) and 0.67 (6½ min). Per‐subject B0 shimming improved the fitted PCr/ATP precision (for 6½ min scans), but had negligible effect on the CR (0.67 versus 0.66).
Conclusions
Both 7 T protocols show improved reproducibility compared with a previous 3 T study by Tyler et al. Our results will enable informed power calculations and protocol selection for future clinical research studies.
We test the reproducibility of two 3D 31P‐MRS CSI protocols at 7 T: one lasting 28 minutes and one lasting 6½ minutes. We observed improved reproducibility even in 6 ½ minutes at 7 T compared to previously reported results for a 31 minute scan at 3 T. Our findings can be used for power calculations when designing future clinical studies using 7 T 31P‐MRS as an endpoint. We test the reproducibility of human cardiac phosphorus MRS ( P-MRS) at ultra-high field strength (7 T) for the first time. The primary motivation of this work was to assess the reproducibility of a 'rapid' 6½ min P three-dimensional chemical shift imaging (3D-CSI) sequence, which if sufficiently reproducible would allow the study of stress-response processes. We compare this with an established 28 min protocol, designed to record high-quality spectra in a clinically feasible scan time. Finally, we use this opportunity to compare the effect of per-subject B shimming on data quality and reproducibility in the 6½ min protocol. 10 healthy subjects were scanned on two occasions: one to test the 28 min 3D-CSI protocol, and one to test the 6½ min protocol. Spectra were fitted using the OXSA MATLAB toolbox. The phosphocreatine to adenosine triphosphate concentration ratio (PCr/ATP) from each scan was analysed for intra- and intersubject variability. The impact of different strategies for voxel selection was assessed. There were no significant differences between repeated measurements in the same subject. For the 28 min protocol, PCr/ATP in the midseptal voxel across all scans was 1.91 ± 0.36 (mean ± intersubject SD). For the 6½ min protocol, PCr/ATP in the midseptal voxel was 1.76 ± 0.40. The coefficients of reproducibility (CRs) were 0.49 (28 min) and 0.67 (6½ min). Per-subject B shimming improved the fitted PCr/ATP precision (for 6½ min scans), but had negligible effect on the CR (0.67 versus 0.66). Both 7 T protocols show improved reproducibility compared with a previous 3 T study by Tyler et al. Our results will enable informed power calculations and protocol selection for future clinical research studies. We test the reproducibility of human cardiac phosphorus MRS (31 P-MRS) at ultra-high field strength (7 T) for the first time. The primary motivation of this work was to assess the reproducibility of a 'rapid' 6½ min 31 P three-dimensional chemical shift imaging (3D-CSI) sequence, which if sufficiently reproducible would allow the study of stress-response processes. We compare this with an established 28 min protocol, designed to record high-quality spectra in a clinically feasible scan time. Finally, we use this opportunity to compare the effect of per-subject B0 shimming on data quality and reproducibility in the 6½ min protocol.PURPOSEWe test the reproducibility of human cardiac phosphorus MRS (31 P-MRS) at ultra-high field strength (7 T) for the first time. The primary motivation of this work was to assess the reproducibility of a 'rapid' 6½ min 31 P three-dimensional chemical shift imaging (3D-CSI) sequence, which if sufficiently reproducible would allow the study of stress-response processes. We compare this with an established 28 min protocol, designed to record high-quality spectra in a clinically feasible scan time. Finally, we use this opportunity to compare the effect of per-subject B0 shimming on data quality and reproducibility in the 6½ min protocol.10 healthy subjects were scanned on two occasions: one to test the 28 min 3D-CSI protocol, and one to test the 6½ min protocol. Spectra were fitted using the OXSA MATLAB toolbox. The phosphocreatine to adenosine triphosphate concentration ratio (PCr/ATP) from each scan was analysed for intra- and intersubject variability. The impact of different strategies for voxel selection was assessed.METHODS10 healthy subjects were scanned on two occasions: one to test the 28 min 3D-CSI protocol, and one to test the 6½ min protocol. Spectra were fitted using the OXSA MATLAB toolbox. The phosphocreatine to adenosine triphosphate concentration ratio (PCr/ATP) from each scan was analysed for intra- and intersubject variability. The impact of different strategies for voxel selection was assessed.There were no significant differences between repeated measurements in the same subject. For the 28 min protocol, PCr/ATP in the midseptal voxel across all scans was 1.91 ± 0.36 (mean ± intersubject SD). For the 6½ min protocol, PCr/ATP in the midseptal voxel was 1.76 ± 0.40. The coefficients of reproducibility (CRs) were 0.49 (28 min) and 0.67 (6½ min). Per-subject B0 shimming improved the fitted PCr/ATP precision (for 6½ min scans), but had negligible effect on the CR (0.67 versus 0.66).RESULTSThere were no significant differences between repeated measurements in the same subject. For the 28 min protocol, PCr/ATP in the midseptal voxel across all scans was 1.91 ± 0.36 (mean ± intersubject SD). For the 6½ min protocol, PCr/ATP in the midseptal voxel was 1.76 ± 0.40. The coefficients of reproducibility (CRs) were 0.49 (28 min) and 0.67 (6½ min). Per-subject B0 shimming improved the fitted PCr/ATP precision (for 6½ min scans), but had negligible effect on the CR (0.67 versus 0.66).Both 7 T protocols show improved reproducibility compared with a previous 3 T study by Tyler et al. Our results will enable informed power calculations and protocol selection for future clinical research studies.CONCLUSIONSBoth 7 T protocols show improved reproducibility compared with a previous 3 T study by Tyler et al. Our results will enable informed power calculations and protocol selection for future clinical research studies. PurposeWe test the reproducibility of human cardiac phosphorus MRS (31P‐MRS) at ultra‐high field strength (7 T) for the first time. The primary motivation of this work was to assess the reproducibility of a ‘rapid’ 6½ min 31P three‐dimensional chemical shift imaging (3D‐CSI) sequence, which if sufficiently reproducible would allow the study of stress‐response processes. We compare this with an established 28 min protocol, designed to record high‐quality spectra in a clinically feasible scan time. Finally, we use this opportunity to compare the effect of per‐subject B0 shimming on data quality and reproducibility in the 6½ min protocol.Methods10 healthy subjects were scanned on two occasions: one to test the 28 min 3D‐CSI protocol, and one to test the 6½ min protocol. Spectra were fitted using the OXSA MATLAB toolbox. The phosphocreatine to adenosine triphosphate concentration ratio (PCr/ATP) from each scan was analysed for intra‐ and intersubject variability. The impact of different strategies for voxel selection was assessed.ResultsThere were no significant differences between repeated measurements in the same subject. For the 28 min protocol, PCr/ATP in the midseptal voxel across all scans was 1.91 ± 0.36 (mean ± intersubject SD). For the 6½ min protocol, PCr/ATP in the midseptal voxel was 1.76 ± 0.40. The coefficients of reproducibility (CRs) were 0.49 (28 min) and 0.67 (6½ min). Per‐subject B0 shimming improved the fitted PCr/ATP precision (for 6½ min scans), but had negligible effect on the CR (0.67 versus 0.66).ConclusionsBoth 7 T protocols show improved reproducibility compared with a previous 3 T study by Tyler et al. Our results will enable informed power calculations and protocol selection for future clinical research studies. |
Author | Ellis, Jane Rodgers, Christopher T. Clarke, William T. Purvis, Lucian A.B. Valkovič, Ladislav |
AuthorAffiliation | 3 Wellcome Centre for Integrative Neuroimaging, FMRIB, Nuffield Department of Clinical Neurosciences University of Oxford UK 4 Wolfson Brain Imaging Centre, Department of Clinical Neurosciences University of Cambridge UK 2 Slovak Academy of Sciences Institute of Measurement Science Bratislava Slovakia 1 OCMR, RDM Cardiovascular Medicine University of Oxford UK |
AuthorAffiliation_xml | – name: 2 Slovak Academy of Sciences Institute of Measurement Science Bratislava Slovakia – name: 3 Wellcome Centre for Integrative Neuroimaging, FMRIB, Nuffield Department of Clinical Neurosciences University of Oxford UK – name: 4 Wolfson Brain Imaging Centre, Department of Clinical Neurosciences University of Cambridge UK – name: 1 OCMR, RDM Cardiovascular Medicine University of Oxford UK |
Author_xml | – sequence: 1 givenname: Jane orcidid: 0000-0002-2396-9741 surname: Ellis fullname: Ellis, Jane email: jane.ellis@rdm.ox.ac.uk organization: University of Oxford – sequence: 2 givenname: Ladislav surname: Valkovič fullname: Valkovič, Ladislav organization: Institute of Measurement Science – sequence: 3 givenname: Lucian A.B. surname: Purvis fullname: Purvis, Lucian A.B. organization: University of Oxford – sequence: 4 givenname: William T. orcidid: 0000-0001-7159-7025 surname: Clarke fullname: Clarke, William T. organization: University of Oxford – sequence: 5 givenname: Christopher T. surname: Rodgers fullname: Rodgers, Christopher T. organization: University of Cambridge |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30924566$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kU1uFDEQhS0URCYBiROgltiERQ9lt3_aGyQYQYiUAAphbbltN-Oouz2xu0Gz4wgcgbPkKJwknkwSfgQLq6yqz0-v_PbQzhAGh9BjDHMMQJ4PTT-nINk9NMMgZYmpJDtoljukrGgNu2gvpXMAqGlFHqDdCiShjPMZWpy6VQx2Mr7xnR_XRWiL5dTroTA6Wq9NsVqGlE-cUnFy-rE4qPCHn9--5-uzQo-FuPxx9hDdb3WX3KObuo8-vXl9tnhbHr8_PFq8PC4NrWpWtq1lBlvSCC0MZg3HnHAJxGjhiGjb3La2ZdhgwW3DJW8clrYBWdcZprLaRy-2uqup6Z01bhij7tQq-l7HtQraqz8ng1-qz-GL4oxyDiILHNwIxHAxuTSq3ifjuk4PLkxJEQIgRAWszujTv9DzMMUhr5cpwqlg-NrRk98d3Vm5_d8MzLeAiSGl6Fpl_KhHHzYGfacwqE2AKgeoNgH-snj34FbzH2i5Rb_6zq3_y6l3r06u-Su1zKkP |
CitedBy_id | crossref_primary_10_1007_s10334_023_01075_1 crossref_primary_10_1093_ehjci_jeac121 crossref_primary_10_1002_mrm_30492 crossref_primary_10_1007_s10741_022_10287_x crossref_primary_10_3389_fphy_2020_00092 crossref_primary_10_2337_dc22_0083 crossref_primary_10_3390_diagnostics14030235 crossref_primary_10_1002_jmri_29445 crossref_primary_10_3389_fphys_2023_1325458 crossref_primary_10_1002_nbm_4950 crossref_primary_10_3389_fphys_2022_793987 crossref_primary_10_1002_mrm_28494 crossref_primary_10_1038_s41598_021_87063_8 crossref_primary_10_3389_fcvm_2023_1068390 crossref_primary_10_1002_mrm_28654 crossref_primary_10_1038_s41598_025_90630_y crossref_primary_10_1002_nbm_4813 crossref_primary_10_3390_metabo12020189 crossref_primary_10_1371_journal_pone_0269957 |
Cites_doi | 10.1002/nbm.701 10.1161/01.CIR.0000072789.89096.10 10.1259/bjr.71.847.9771379 10.1002/mrm.24922 10.1002/nbm.1192 10.1161/01.CIR.86.6.1810 10.1016/j.cardfail.2013.05.008 10.1007/s00330-006-0170-0 10.1081/JCMR-120016387 10.1148/radiol.2016152629 10.1136/hrt.2004.047985 10.1186/1532-429X-12-S1-P123 10.1002/mrm.1910250205 10.1161/CIRCULATIONAHA.109.934059 10.1056/NEJMra063052 10.1371/journal.pone.0187153 10.1371/journal.pone.0185356 10.1038/ncpcardio1158 10.1093/eurheartj/16.suppl_O.115 10.1002/mrm.1144 10.1006/jmre.1997.1244 10.1073/pnas.0408962102 10.1002/nbm.1350 10.3389/fphys.2017.00939 10.1161/01.CIR.92.1.15 10.1016/S0735-1097(02)02160-5 10.1002/mrm.22230 10.1002/(SICI)1099-1492(199608)9:5<217::AID-NBM419>3.0.CO;2-G 10.1080/01621459.1974.10482955 |
ContentType | Journal Article |
Copyright | 2019 The Authors. published by John Wiley & Sons Ltd. 2019 The Authors. NMR in Biomedicine published by John Wiley & Sons Ltd. 2019 John Wiley & Sons, Ltd. |
Copyright_xml | – notice: 2019 The Authors. published by John Wiley & Sons Ltd. – notice: 2019 The Authors. NMR in Biomedicine published by John Wiley & Sons Ltd. – notice: 2019 John Wiley & Sons, Ltd. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 8FD FR3 K9. P64 7X8 5PM |
DOI | 10.1002/nbm.4095 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Physics |
DocumentTitleAlternate | Ellis et al |
EISSN | 1099-1492 |
EndPage | n/a |
ExternalDocumentID | PMC6546607 30924566 10_1002_nbm_4095 NBM4095 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Medical Research Council funderid: HST00040/HS00.1 – fundername: Vedecká Grantová Agentúra MŠVVaŠ SR a SAV funderid: #2/0001/17 – fundername: Agentúra na Podporu Výskumu a Vývoja funderid: #15‐0029 – fundername: Sir Henry Dale Fellowship from the Wellcome Trust and the Royal Society funderid: 098436/Z/12/B – fundername: Agentúra na Podporu Výskumu a Vývoja grantid: #15-0029 – fundername: Vedecká Grantová Agentúra MŠVVaŠ SR a SAV grantid: #2/0001/17 – fundername: Medical Research Council grantid: HST00040/HS00.1 – fundername: Wellcome Trust grantid: 098436 – fundername: Sir Henry Dale Fellowship from the Wellcome Trust and the Royal Society grantid: 098436/Z/12/B – fundername: Agentúra na Podporu Výskumu a Vývoja grantid: #15‐0029 |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 24P 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52V 52W 52X 53G 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACFBH ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFFPM AFGKR AFRAH AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AIACR AIDQK AIDYY AIQQE AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG P2P P2W P2X P2Z P4D PALCI Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 UB1 V2E W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WVDHM WXSBR XG1 XPP XV2 ZZTAW ~IA ~WT AAHHS AAYXX ACCFJ AEEZP AEQDE AIWBW AJBDE CITATION CGR CUY CVF ECM EIF NPM 7QO 8FD FR3 K9. P64 7X8 5PM |
ID | FETCH-LOGICAL-c4385-ffd5c1d2b7a7c15b61626902ca7e27ff7a7ddf51c176db696be19db09885b6493 |
IEDL.DBID | DR2 |
ISSN | 0952-3480 1099-1492 |
IngestDate | Thu Aug 21 18:27:31 EDT 2025 Fri Jul 11 03:12:13 EDT 2025 Fri Jul 25 09:58:20 EDT 2025 Mon Jul 21 06:02:39 EDT 2025 Thu Apr 24 23:08:58 EDT 2025 Tue Jul 01 02:45:42 EDT 2025 Thu Sep 25 07:34:59 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | 31P 7 T human reproducibility MRS cardiac |
Language | English |
License | Attribution 2019 The Authors. NMR in Biomedicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4385-ffd5c1d2b7a7c15b61626902ca7e27ff7a7ddf51c176db696be19db09885b6493 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-2396-9741 0000-0001-7159-7025 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fnbm.4095 |
PMID | 30924566 |
PQID | 2226475149 |
PQPubID | 2029982 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6546607 proquest_miscellaneous_2200773058 proquest_journals_2226475149 pubmed_primary_30924566 crossref_citationtrail_10_1002_nbm_4095 crossref_primary_10_1002_nbm_4095 wiley_primary_10_1002_nbm_4095_NBM4095 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | June 2019 |
PublicationDateYYYYMMDD | 2019-06-01 |
PublicationDate_xml | – month: 06 year: 2019 text: June 2019 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford – name: Hoboken |
PublicationTitle | NMR in biomedicine |
PublicationTitleAlternate | NMR Biomed |
PublicationYear | 2019 |
Publisher | Wiley Subscription Services, Inc John Wiley and Sons Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc – name: John Wiley and Sons Inc |
References | 2010; 12 2009; 22 2017; 8 1995; 92 1995; 16 2006; 16 2010; 122 2002; 4 2008; 5 2016; 281 2004; 90 2001; 45 2010; 63 2007; 356 2013; 19 1974; 69 2003; 107 1997; 129 2005; 102 2002; 40 2017; 12 1992; 25 2014 1998; 71 1992; 86 2007; 20 2014; 72 2001; 14 1996; 9 e_1_2_8_28_1 e_1_2_8_29_1 e_1_2_8_24_1 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_22_1 e_1_2_8_23_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_14_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_12_1 Rodgers CT (e_1_2_8_13_1) 2014 e_1_2_8_30_1 |
References_xml | – volume: 63 start-page: 881 issue: 4 year: 2010 end-page: 891 article-title: Receive array magnetic resonance spectroscopy: whitened singular value decomposition (WSVD) gives optimal Bayesian solution publication-title: Magn Reson Med – volume: 45 start-page: 1095 issue: 6 year: 2001 end-page: 1102 article-title: BISTRO: an outer‐volume suppression method that tolerates RF field inhomogeneity publication-title: Magn Reson Med – volume: 129 start-page: 35 issue: 1 year: 1997 end-page: 43 article-title: Improved method for accurate and efficient quantification of MRS data with use of prior knowledge publication-title: J Magn Reson – volume: 12 issue: Suppl 1 year: 2010 article-title: Development and validation of a short 31P cardiac magnetic resonance spectroscopy protocol publication-title: J Cardiovasc Magn Reson – volume: 12 issue: 10 year: 2017 article-title: Using a whole‐body P birdcage transmit coil and 16‐element receive array for human cardiac metabolic imaging at 7T publication-title: PLoS ONE – volume: 356 start-page: 1140 issue: 11 year: 2007 end-page: 1151 article-title: The failing heart—an engine out of fuel publication-title: N Engl J Med – year: 2014 article-title: A 16‐element receive array for human cardiac 31P MR spectroscopy at 7T publication-title: Proc Int Soc Magn Reson Med – volume: 281 start-page: 409 issue: 2 year: 2016 end-page: 417 article-title: Dilated cardiomyopathy: phosphorus 31 MR spectroscopy at 7 T publication-title: Radiology – volume: 69 start-page: 364 issue: 346 year: 1974 end-page: 367 article-title: Robust tests for the equality of variances publication-title: J Am Stat Assoc – volume: 122 start-page: 1562 issue: 16 year: 2010 end-page: 1569 article-title: Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy publication-title: Circulation – volume: 86 start-page: 1810 issue: 6 year: 1992 end-page: 1818 article-title: 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high‐energy phosphate metabolism in heart failure publication-title: Circulation – volume: 14 start-page: 278 issue: 4 year: 2001 end-page: 283 article-title: Cramér‐Rao bounds: an evaluation tool for quantitation publication-title: NMR Biomed – volume: 5 start-page: S49 year: 2008 end-page: S56 article-title: Detection of myocardial disorders by magnetic resonance spectroscopy publication-title: Nat Clin Pract Cardiovasc Med – volume: 16 start-page: 1796 issue: 8 year: 2006 end-page: 1802 article-title: P‐MR spectroscopic imaging in hypertensive heart disease publication-title: Eur Radiol – volume: 8 start-page: 939 year: 2017 article-title: Human cardiac P‐MR spectroscopy at 3 tesla cannot detect failing myocardial energy homeostasis during exercise publication-title: Front Physiol – volume: 40 start-page: 1267 issue: 7 year: 2002 end-page: 1274 article-title: Absolute concentrations of high‐energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with P‐SLOOP magnetic resonance spectroscopy publication-title: J Am Coll Cardiol – volume: 16 start-page: 115 issue: Suppl O year: 1995 end-page: 118 article-title: Contributions of 31P‐magnetic resonance spectroscopy to the understanding of dilated heart muscle disease publication-title: Eur Heart J – volume: 20 start-page: 555 issue: 6 year: 2007 end-page: 565 article-title: Absolute quantification of phosphorus metabolite concentrations in human muscle by P MRS: a quantitative review publication-title: NMR Biomed – volume: 72 start-page: 304 issue: 2 year: 2014 end-page: 315 article-title: Human cardiac P magnetic resonance spectroscopy at 7 tesla publication-title: Magn Reson Med – volume: 25 start-page: 260 issue: 2 year: 1992 end-page: 272 article-title: Metabolic response of the human heart to inotropic stimulation: in vivo phosphorus‐31 studies of normal and cardiomyopathic myocardium publication-title: Magn Reson Med – volume: 9 start-page: 217 issue: 5 year: 1996 end-page: 227 article-title: Reproducibility of human cardiac P‐NMR spectroscopy publication-title: NMR Biomed – volume: 102 start-page: 808 issue: 3 year: 2005 end-page: 813 article-title: ATP flux through creatine kinase in the normal, stressed, and failing human heart publication-title: Proc Natl Acad Sci – volume: 12 issue: 9 year: 2017 article-title: OXSA: an open‐source magnetic resonance spectroscopy analysis toolbox in MATLAB publication-title: PLoS ONE – volume: 4 start-page: 493 issue: 4 year: 2002 end-page: 502 article-title: Decreased high‐energy phosphate ratios in the myocardium of men with diabetes mellitus type I publication-title: J Cardiovasc Magn Reson – volume: 90 start-page: 23 year: 2004 end-page: 30 article-title: BSE procedure guidelines for the clinical application of stress echocardiography, recommendations for performance and interpretation of stress echocardiography: a report of the British Society of Echocardiography Policy Committee publication-title: Heart – volume: 19 start-page: 454 issue: 7 year: 2013 end-page: 460 article-title: Exercise‐induced decrease in myocardial high‐energy phosphate metabolites in patients with Chagas heart disease publication-title: J Card Fail – volume: 92 start-page: 15 issue: 1 year: 1995 end-page: 23 article-title: Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by P magnetic resonance spectroscopy publication-title: Circulation – volume: 107 start-page: 3040 issue: 24 year: 2003 end-page: 3046 article-title: Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes publication-title: Circulation – volume: 22 start-page: 405 issue: 4 year: 2009 end-page: 413 article-title: Reproducibility of P cardiac magnetic resonance spectroscopy at 3 T publication-title: NMR Biomed – volume: 71 start-page: 704 issue: 847 year: 1998 end-page: 707 article-title: Signal‐to‐noise ratio in MRI publication-title: Br J Radiol – ident: e_1_2_8_19_1 doi: 10.1002/nbm.701 – ident: e_1_2_8_5_1 doi: 10.1161/01.CIR.0000072789.89096.10 – ident: e_1_2_8_11_1 doi: 10.1259/bjr.71.847.9771379 – ident: e_1_2_8_12_1 doi: 10.1002/mrm.24922 – ident: e_1_2_8_22_1 doi: 10.1002/nbm.1192 – ident: e_1_2_8_7_1 doi: 10.1161/01.CIR.86.6.1810 – ident: e_1_2_8_28_1 doi: 10.1016/j.cardfail.2013.05.008 – ident: e_1_2_8_6_1 doi: 10.1007/s00330-006-0170-0 – ident: e_1_2_8_4_1 doi: 10.1081/JCMR-120016387 – ident: e_1_2_8_21_1 doi: 10.1148/radiol.2016152629 – ident: e_1_2_8_23_1 doi: 10.1136/hrt.2004.047985 – ident: e_1_2_8_24_1 doi: 10.1186/1532-429X-12-S1-P123 – ident: e_1_2_8_31_1 doi: 10.1002/mrm.1910250205 – ident: e_1_2_8_30_1 doi: 10.1161/CIRCULATIONAHA.109.934059 – year: 2014 ident: e_1_2_8_13_1 article-title: A 16‐element receive array for human cardiac 31P MR spectroscopy at 7T publication-title: Proc Int Soc Magn Reson Med – ident: e_1_2_8_2_1 doi: 10.1056/NEJMra063052 – ident: e_1_2_8_27_1 doi: 10.1371/journal.pone.0187153 – ident: e_1_2_8_17_1 doi: 10.1371/journal.pone.0185356 – ident: e_1_2_8_3_1 doi: 10.1038/ncpcardio1158 – ident: e_1_2_8_10_1 doi: 10.1093/eurheartj/16.suppl_O.115 – ident: e_1_2_8_14_1 doi: 10.1002/mrm.1144 – ident: e_1_2_8_18_1 doi: 10.1006/jmre.1997.1244 – ident: e_1_2_8_9_1 doi: 10.1073/pnas.0408962102 – ident: e_1_2_8_16_1 doi: 10.1002/nbm.1350 – ident: e_1_2_8_25_1 doi: 10.3389/fphys.2017.00939 – ident: e_1_2_8_8_1 doi: 10.1161/01.CIR.92.1.15 – ident: e_1_2_8_29_1 doi: 10.1016/S0735-1097(02)02160-5 – ident: e_1_2_8_15_1 doi: 10.1002/mrm.22230 – ident: e_1_2_8_26_1 doi: 10.1002/(SICI)1099-1492(199608)9:5<217::AID-NBM419>3.0.CO;2-G – ident: e_1_2_8_20_1 doi: 10.1080/01621459.1974.10482955 |
SSID | ssj0008432 |
Score | 2.370349 |
Snippet | Purpose
We test the reproducibility of human cardiac phosphorus MRS (31P‐MRS) at ultra‐high field strength (7 T) for the first time. The primary motivation of... We test the reproducibility of human cardiac phosphorus MRS ( P-MRS) at ultra-high field strength (7 T) for the first time. The primary motivation of this work... PurposeWe test the reproducibility of human cardiac phosphorus MRS (31P‐MRS) at ultra‐high field strength (7 T) for the first time. The primary motivation of... We test the reproducibility of human cardiac phosphorus MRS (31 P-MRS) at ultra-high field strength (7 T) for the first time. The primary motivation of this... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e4095 |
SubjectTerms | 31P 7 T Adenosine triphosphate Adenosine Triphosphate - metabolism Adult ATP Biological products cardiac Chemical equilibrium Female Field strength Heart human Humans Magnetic Resonance Spectroscopy Male Motivation MRS Myocardium - metabolism Organic chemistry Phosphocreatine Phosphocreatine - metabolism Phosphorus Phosphorus - metabolism Reproducibility Reproducibility of Results Sample Size Time Factors |
Title | Reproducibility of human cardiac phosphorus MRS (31P‐MRS) at 7 T |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fnbm.4095 https://www.ncbi.nlm.nih.gov/pubmed/30924566 https://www.proquest.com/docview/2226475149 https://www.proquest.com/docview/2200773058 https://pubmed.ncbi.nlm.nih.gov/PMC6546607 |
Volume | 32 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0952-3480 databaseCode: DR2 dateStart: 19960101 customDbUrl: isFulltext: true eissn: 1099-1492 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0008432 providerName: Wiley-Blackwell |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL2CSkA3PAYogVIZCfFYZBo7jh0vYURVIU1VlVaqxCLyU0UtmaqZWdBVP4FP4Fv4FL4E23nQoSAhFlGi-CZx7Gv72L73XIDnjmErrbWpLEqRUmNkKrgUKRfCA1inPagLC_rTHbZ9QN8fFoedVWXwhWn5IYYFt9AyYn8dGrhUzeYl0lD1eewnJ8G_HOdF3KHd-8UcVdIYm8ynkzSnZdbzzmZks39weSS6Ai-vWkleRq9x-Nm6Ax_7jLdWJ8fjxVyN9flvnI7_92d34XaHStGbVo3uwTVbj-DWpA8GN4Kb024PfgQ3otGobu7DxKP3SBjbWth-QTOHYsw_pKPeaXR6NGv8cbZo0HTvA3qV490fF1_95Wsk54h__7b_AA623u1PttMuKEOqaV4WqXOm0NgQxSXXuFAM-ymRyIiW3BLunL9tjCuwxpwZxQRTFgujMlGWXpiK_CGs1LPaPgJEnWGEulzkhtNCYGVFgJ9EOpUxoXECL_sKqnTHWB4CZ5xULdcyqXxJVaGkEng2SJ62LB1_kFnv67jq2mlTkeBHzD1oFP4VQ7Iv27BtIms7WwSZwHnk-8UygbVWJYaP5JkIO8csAb6kLINAYO9eTqk_HUUW7-BFxjKewIuoC3_Nd7XzdhrOj_9V8AmselQnWnu2dViZny3sU4-c5moDrhO6uxFbyk9iRBYq |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3LbtQwFL0qRVA2CIZXoICRENBFaOw4dixWMKIaoBlVMJW6i_xUkdpM1ZlZsOMT-AS-hU_hS7CdhzoqSCyiRPHNQ_f6cXx9fS7Ac8ewldbaVBalSKkxMhVcipQL4QGs0x7UBYd-NWWTQ_rxqDjagDf9XpiWH2JwuIWWEfvr0MCDQ3r3AmuoOn3tZyfFFbhKGclClSb0YOiGSxqzk3kBkua0zHrm2Yzs9k-uj0WXAOblOMmL-DUOQHu34GaHHNHb1tS3YcM2I9ga9wnbRnC96tbJR3AtBnbqxR0Ye4QdSV3bKNhvaO5QzMuHdKwbGp0dzxf-OF8tUPX5C3qV44Pf33_4yx0kl4j_-jm7C4d772fjSdolTkg1zcsidc4UGhuiuOQaF4phP20RGdGSW8Kd87eNcQXWmDOjmGDKYmFUJsrSC1OR34PNZt7YB4CoM4xQl4vccFoIrKwIEJFIpzImNE7gZa_CWnes4iG5xUnd8iGT2iu7DspO4NkgedYyafxFZru3Qt21pUVNwl5f7oGd8K8Yir1uw9KGbOx8FWQCL5Hvu8oE7rdGGz6SZyKs7rIE-Jo5B4HAsL1e0nw9jkzbYacXy3gCL6Lh__nf9fRdFc4P_1fwKWxNZtV-vf9h-ukR3PAoTLTxZ9uwuTxf2cce6SzVk1ij_wCfw_je |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL2CItpueAwUUgoYCfFYZBonjh0vYWBUHjOqSitVYhH5qSIgM-rMLNoVn8An8C18Cl-C7TzoUJAQiyhRfJM49r32sX19LsBDS7ERxphY5AWPidYi5kzwmHHuAKxVDtT5Cf3RmO4ckNeH-WHjVen3wtT8EN2Em7eM0F57A59qu32GNFR-7rvBSX4RLhHqBlceEO39oo4qSAhO5gTSOCNF0hLPJul2--RyV3QOX553kzwLX0P_M7wK79uc124nH_uLueyr099IHf_v167BlQaWome1Hl2HC6bqwdqgjQbXg9VRswjfg8vBa1TNbsDAwffAGFu72J6giUUh6B9SQfEUmh5NZu44XszQaO8depLh3R9fvrrLp0jMEfv-bf8mHAxf7g924iYqQ6xIVuSxtTpXWKeSCaZwLil2YyKepEowkzJr3W2tbY4VZlRLyqk0mGuZ8KJwwoRnG7BSTSpzGxCxmqbEZjzTjOQcS8M9_kyFlQnlCkfwuK2gUjWU5T5yxqeyJltOS1dSpS-pCB50ktOapuMPMlttHZeNoc7K1G8kZg41cveKLtmVrV83EZWZLLyMJz1yDWMRwa1aJbqPZAn3S8c0ArakLJ2Ap-9eTqk-HAUab7-NjCYsgkdBF_6a73L8fOTPm_8qeB9Wd18My7evxm_uwLpDeLz2bduClfnxwtx1KGou7wVz-QnHHBge |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reproducibility+of+human+cardiac+phosphorus+MRS+%2831+P-MRS%29+at+7+T&rft.jtitle=NMR+in+biomedicine&rft.au=Ellis%2C+Jane&rft.au=Valkovi%C4%8D%2C+Ladislav&rft.au=Purvis%2C+Lucian+A+B&rft.au=Clarke%2C+William+T&rft.date=2019-06-01&rft.issn=1099-1492&rft.eissn=1099-1492&rft.volume=32&rft.issue=6&rft.spage=e4095&rft_id=info:doi/10.1002%2Fnbm.4095&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0952-3480&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0952-3480&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0952-3480&client=summon |